Shepherd Kaplan Krochuk’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-19,475
Closed -$144K 327
2015
Q4
$144K Buy
19,475
+8,000
+70% +$56.4K 0.04% 316
2015
Q3
$68K Sell
11,475
-8,229
-42% -$67.1K 0.02% 351
2015
Q2
$155K Sell
19,704
-6,663
-25% -$45.8K 0.03% 340
2015
Q1
$166K Sell
26,367
-8,100
-24% -$51.1K 0.03% 307
2014
Q4
$171K Hold
34,467
0.03% 372
2014
Q3
$171K Hold
34,467
0.02% 452
2014
Q2
$152K Buy
34,467
+4,000
+13% +$16.8K 0.02% 476
2014
Q1
$146K Hold
30,467
0.02% 494
2013
Q4
$130K Sell
30,467
-826
-3% -$3.58K 0.02% 476
2013
Q3
$148K Buy
+31,293
New +$122K 0.02% 471

Other funds holding ICCC

Shepherd Kaplan Krochuk's ICCC Position: Q1 2016 in Review

Shepherd Kaplan Krochuk sold out of ImmuCell (ICCC) in Q1 2016, closing a stake of 19,475 shares — an estimated $144K sold.

Shepherd Kaplan Krochuk first reported a position in ICCC in Q3 2013 and held it in 10 quarters. The position peaked at $171K in Q4 2014. 21 funds tracked by Wall St. Rank hold ICCC as of Q1 2016.

  • Shepherd Kaplan Krochuk reported no remaining ImmuCell position as of Q1 2016 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 19,475 ImmuCell shares in Q1 2016, an estimated $144K.
  • Shepherd Kaplan Krochuk first reported a position in ImmuCell in Q3 2013 and held it in 10 quarters.
  • Shepherd Kaplan Krochuk's ImmuCell position peaked at $171K in Q4 2014.
  • 21 funds tracked by Wall St. Rank held ImmuCell as of Q1 2016.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2016, filed 16 May 2016.